Abstract. Pre(sub)clinical Cushing's disease is a recently described entity defined by the autonomous secretion of ACTH and the absence of a cushingoid appearance. We screened 77 hospitalized patients with diabetes mellitus for subclinical hypercortisolism and detected pre(sub)clinical Cushing's disease in 2 (2.6%) of them. In both patients, transsphenoidal surgery was performed and a microadenoma was removed. Their metabolic clearance rate of glucose measured by a glucose clamp study, an index of insulin sensitivity, significantly improved after surgery. Our results indicate that screening for subclinical hypercortisolism in diabetic patients might be useful, as surgery improves glucose tolerance and insulin sensitivity.
THE prevalence of subclinical hypercortisolism in patients with diabetes mellitus in Western countries is higher than previously believed [1] [2] [3] , but it is not known whether this is the case in Japan. Screening and detection of subclinical hypercortisolism in diabetic patients might be useful because surgery may improve glucose tolerance.
Pre(sub)clinical Cushing's disease is a recently described entity defined by the autonomous secretion of ACTH and the absence of a cushingoid appearance [4] , and the diagnostic criteria were recently published in Japan. We screened hospitalized patients with diabetes mellitus for subclinical hypercortisolism. In patients in whom pre(sub)clinical Cushing's disease was detected, transsphenoidal surgery was performed. Insulin sensitivity was assessed with the glucose clamp technique before and after surgery.
Methods
The subjects were recruited from 135 consecutive patients admitted to Ohtsu Red Cross Hospital for control of diabetes mellitus from September 2005 to September 2006. Exclusion criteria were cushingoid appearance, type 1 diabetes, diabetes secondary to other causes, alcoholism, renal failure, depression, and acute illness. A total of 77 patients (47 males and 30 females, age 61 ± 13 years, BMI 25.0 ± 4.2, HbA1c 10.4 ± 2.1%) were studied. None of the patients displayed moon face, buffalo hump, central obesity, striae cutis, skin atrophy, ecchymosis, or weakness associated with proximal muscle wasting. The study protocol was approved by the hospital ethics committee, and informed consent was obtained from all patients.
After at least 36 h after admission , the serum cortisol concentration was measured between 2300 and 2400 h (midnight cortisol). Although the cut-off value of midnight cortisol for screening is 2.5 µg/dl according to the diagnostic criteria for pre(sub)clinical Cushing's disease (Guidelines of Diagnosis and Treatment of Pre(sub)clinical Cushing's Disease by the Research Committee of the Ministry of Health, Labor, and Wel-fare of Japan, 2006), we set the cut-off value as 5 µg/dl because the diurnal rhythm of cortisol is insufficient in diabetic patients [5] . Patients with a midnight cortisol level of more than 5.0 µg/dl underwent a 0.5 mg overnight dexamethasone suppression test (DST). Patients in whom the plasma cortisol levels were greater than 3 µg/dl after the 0.5 mg overnight DST were regarded as positive according to the diagnostic criteria, and basal ACTH and cortisol levels were measured. Patients with ACTH levels above 10 pg/ml underwent dynamic magnetic resonance imaging (MRI) of the pituitary. Abdominal computed tomography would have been performed in patients with ACTH levels of less than 10 pg/ml, however none of the patients had such low levels.
After improvement of glycemic control by medical treatment and stabilization for 4 to 6 months, transsphenoidal surgery was performed and a microadenoma was identified and removed in patients diagnosed with pre(sub)clinical Cushing's disease.
A euglycemic hyperinsulinemic glucose clamp study was performed 1 week before and 4 to 6 weeks after surgery as described earlier [6] with slight modification [7] . Serum C-peptide values were measured 6 min after intravenous administration of 1 mg glucagon before and after surgery.
Results
Of the 77 patients, 27 patients had a midnight cortisol level of more than 5.0 µg/dl. Among these 27, there were 7 in whom plasma cortisol levels were greater than 3 µg/dl after the 0.5 mg overnight DST. One patient declined further study. Basal ACTH and cortisol levels were measured in the other 6 patients, all of whom had ACTH levels above 10 pg/ml. Dynamic MRI of the pituitary revealed cystic lesions in two of the patients, and the findings in the other 4 patients were normal.
The endocrinologic data of the two patients with positive MRI findings are shown in Table 1 . Basal ACTH and cortisol levels were normal, and the peak/ basal ratio of plasma ACTH after a CRH stimulation test was above 1.5. Serum cortisol was not suppressed by an overnight low-dose (0.5 mg) DST, but was suppressed by an overnight high-dose (8 mg) DST. The central-peripheral ratio of ACTH measured by bilateral simultaneous sampling of the cavernous sinuses after stimulation with 100 µg CRH was above 3.0. Both patients were diagnosed with pre(sub)clinical Cushing's disease based on the diagnostic criteria. Transsphenoidal surgery was performed and a microadenoma was identified and removed in both patients. The pathologic diagnosis based on immunohistochemistry was an After improvement of glycemic control by medical treatment and stabilization for 4 to 6 months, transsphenoidal surgery was performed. A euglycemic hyperinsulinemic glucose clamp study was performed 1 week before and 4 to 6 weeks after surgery. Hydrocortisone replacement therapy was stopped 2.5 weeks after surgery. Post-op, post-operation; MCR-G, metabolic clearance rate of glucose measured by a euglycemic hyperinsulinemic glucose clamp study; CPR; serum C-peptide ACTH-secreting adenoma. Patient 2 had transient hypoglycemia postoperatively. In both patients, however, the ACTH and cortisol response after stimulation with CRH 2 weeks after surgery was normal, consistent with preoperative pre(sub)clinical Cushing's disease without severe suppression of the residual pituitary gland, and hydrocortisone replacement therapy was stopped. Serum cortisol was suppressed by an overnight low-dose (0.5 mg) DST.
The diabetologic data of the two patients are shown in Table 2 . Neither patient had a family history of diabetes. Glucose tolerance improved after surgery in both patients.
Notably, the metabolic clearance rate of glucose measured by a glucose clamp study, an index of insulin sensitivity, significantly improved after surgery. There was no significant difference between the serum C-peptide values 6 min after intravenous administration of 1 mg of glucagon before and after surgery. Patient 1 required mixed insulin at 20 U/day to control blood glucose levels before surgery; the dose was reduced to 6 U/day after surgery, and the patient is currently under good control on oral hypoglycemic agents. Patient 2 was able to stop taking an oral hypoglycemic agent after surgery.
The blood pressure of Patients 1 and 2 was 140/ 75 mmHg and 132/74 mmHg preoperatively, and 125/ 70 and 110/70 mmHg postoperatively, respectively. Patient 1 was taking antihypertensive drugs, the dosages of which were not changed either before or after surgery. Although bone mineral density was not measured, osteoporosis was observed in the thoracic spine in a lateral view chest X-ray in Patient 2, which improved 8 months after surgery.
Discussion
The prevalence of subclinical hypercortisolism in diabetic patients in Western countries is reported to be 2% to 9.4%, depending on the population studied and the diagnostic criteria [1] [2] [3] . In the present study, we detected 2 patients with pre(sub)clinical Cushing's disease (2.6%) out of 77 hospitalized diabetic patients. Our findings suggest that the prevalence of subclinical hypercortisolism in diabetic patients in Japan might be higher than expected, although further studies with larger numbers of patients are required to determine the actual prevalence.
Because glucose tolerance and insulin sensitivity improved after surgery in both patients, screening for subclinical hypercortisolism in diabetic patients might be useful. This is the first report of pre(sub)clinical Cushing's disease with the insulin sensitivity and secretion evaluated by a euglycemic hyperinsulinemic glucose clamp study and glucagon test before and after surgery. It is unlikely that the improved insulin sensitivity was the result of ameliorated glucose toxicity, because a preoperative glucose clamp test was performed after glycemic control had been stabilized for 4 to 6 months.
The mechanism of insulin resistance in pre(sub)clinical Cushing's disease without clinical features of Cushing's disease remains speculative. One possible explanation is that sensitivity to cortisol may differ among tissues. Another possibility is that differences in the activity of 11βHSD-1, an enzyme that generates active cortisol from inactive cortisone, may cause differences in glucocorticoid actions among various tissues [8] .
There are some limitations in this study. The possibility that midnight cortisol was increased due to venipuncture cannot be excluded. In this sense, screening by midnight salivary cortisol is promising [9] , although this is currently not clinically available in Japan. Although various approaches have been studied, there is no single screening test that can detect all cases of F; serum cortisol, DST; dexamethasone suppression test, MRI; magnetic resonance imaging subclinical hypercortisolism. Combination of a 0.5-mg overnight DST and midnight cortisol might be desirable [10] , although the risk of causing hyperglycemia in uncontrolled diabetic patients is not negligible. We performed DST in patients screened by midnight cortisol after fair glycemic control was achieved.
The detection rate of a pituitary adenoma in Cushing's disease by dynamic MRI is approximately 60%. Indeed, in the present two cases of pre(sub)clinical Cushing's disease, microadenoma was found apart from the cysts detected by preoperative MRI. In 4 cases with negative MRI findings, the plasma cortisol levels after the 0.5-mg overnight DST were between 3 and 5 µg/dl, and basal ACTH levels were between 44.5 and 65.5 pg/ml. Thus, ectopic ACTH syndrome or adrenogenic preclinical Cushing's syndrome is unlikely. All four cases had hypertension. Pre(sub)clinical Cushing's disease cannot be excluded, but the patients were reluctant to undergo further studies including sampling of the cavernous sinuses. Therefore, we might have underestimated the prevalence of pre(sub)clinical Cushing's disease in the present study.
In conclusion, screening for subclinical hypercortisolism in diabetic patients might be useful , as glucose tolerance and insulin sensitivity improve after surgery.
